These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7426887)

  • 1. Adverse reactions to urographic contrast medium. Rapid versus slow injection rate.
    Jensen N; Dorph S
    Br J Radiol; 1980 Jul; 53(631):659-61. PubMed ID: 7426887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Accidents caused by contrast media used in uro-angiography].
    Peter JD
    Anesth Analg (Paris); 1977; 34(5):1029-37. PubMed ID: 77647
    [No Abstract]   [Full Text] [Related]  

  • 3. Why does kidney size change during I.V. urography?
    Dorph S; Sovak M; Talner LB; Rosen L
    Invest Radiol; 1977; 12(3):246-50. PubMed ID: 863628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrast agent induced thrombophlebitis following leg phlebography: iopamidol versus meglumine iothalamate.
    Lea Thomas M; Keeling FP; Piaggio RB; Treweeke PS
    Br J Radiol; 1984 Mar; 57(675):205-7. PubMed ID: 6365232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrast and electrolyte dynamics of the intravenous pyelogram. II. Disparities in serum and urine concentrations of meglumine and anion.
    Lasser EC; Lang JH; Hamblin AE; Rosen L
    Invest Radiol; 1975; 10(4):307-13. PubMed ID: 1184320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of renal function before and after intravenous injection of uroangiographic water soluble contrast media in men.
    Verbaeys A; Lameire N; Oosterlinck W
    Acta Urol Belg; 1989; 57(4):795-801. PubMed ID: 2631582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Histamine liberation through renal roentgen contrast media: comparison of iopamidol and meglumine ioglicinate].
    Gmeinwieser J; Reimann HJ; Reiser M
    Rontgenpraxis; 1985 Nov; 38(11):396-9. PubMed ID: 2417338
    [No Abstract]   [Full Text] [Related]  

  • 8. [Adverse reactions following high-dose intravenous injection of urographic contrast media].
    Lackner K; Köster O; von Uexküll V; Broich H
    Rofo; 1984 Oct; 141(4):447-52. PubMed ID: 6436920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical evaluation of cardiovascular reactions to renal contrast media using an impedance method (author's transl)].
    Brutschin P; Vock P; Fuchs WA
    Rofo; 1976 Oct; 125(4):365-71. PubMed ID: 136404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic response to excretory urography. Work in progress.
    Fischer HW; Katzberg RW; Morris TW; Spataro RF
    Radiology; 1984 Apr; 151(1):31-3. PubMed ID: 6701329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of the side effects of urographic contrast media (iothalamate, diatrizoate, iodamide, iopamidol) within the scope of a CT study].
    Stellamor K; Hruby W; Assinger S; Luckner H
    Radiologe; 1984 Oct; 24(10):488-90. PubMed ID: 6505221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of tri-iodoisophthaldiamide with meglumine lothalamate in phlebography of the leg.
    Thomas ML; Briggs GM
    AJR Am J Roentgenol; 1982 Apr; 138(4):725-7. PubMed ID: 7039276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of contrast media in cerebral angiography: iopamidol vs. methylglucamine iothalamate.
    Bird CR; Drayer BP; Velaj R; Triolo PJ; Allen S; Bates M; Yeates AE; Heinz ER; Osborne DR
    AJNR Am J Neuroradiol; 1984; 5(6):801-3. PubMed ID: 6437183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Convulsions subarachnoid haemorrhage and death following myelography with meglumine iothalamate 280.
    Bagchi AK
    Surg Neurol; 1976 May; 5(5):285-6. PubMed ID: 1265645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Severe reactions caused by Conray-400 used in ventriculography and myelography].
    Li ZX
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1982 Sep; 15(3):141-2. PubMed ID: 6983954
    [No Abstract]   [Full Text] [Related]  

  • 16. The old and the new: a study of five contrast media for urography.
    Davies P; Panto PN; Buckley J; Richardson RE
    Br J Radiol; 1985 Jul; 58(691):593-7. PubMed ID: 3893610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Adverse reactions to high osmolarity contrast media. A comparative-prospective study].
    Urrutia M; Macharaviaya A; Rodríguez R
    Rev Med Panama; 1994 Jan; 19(1):19-26. PubMed ID: 7938712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of glomerular filtration rate by fluorescent excitation of non-radioactive meglumine iothalamate.
    Guesry P; Kaufman L; Orloff S; Nelson JA; Swann S; Holliday M
    Clin Nephrol; 1975; 3(4):134-8. PubMed ID: 1149336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Digital vascular imaging: practical aspects.
    Eskridge JM; Becker GJ; Rabe FE; Holden RW; Klatte EC
    Radiology; 1983 Sep; 148(3):703-5. PubMed ID: 6878689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urographic contrast agents. Comparison of sodium and methylglucamine salts of iothalamate monomer and dimer.
    Benness GT; Glazer M
    Clin Radiol; 1973 Oct; 24(4):445-8. PubMed ID: 4621054
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.